Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

Summary

The objective of this clinical trial was to evaluate whether DF2156A has a potential in improving the clinical outcome in patients with active blistering bullous pemphigoid (BP) to warrant its further development. The safety of DF2156A in the specific clinical setting was also evaluated.

Timeline

Start

2012-02-20

Primary completion

2012-07-05

Completion

2012-07-05

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of efficacy observed at 1/3 of the enrollment at investigated dosage. No results available.”

Drugs

Indications